Mainz, Germany

Jorge Herrero Moreno

USPTO Granted Patents = 1 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Jorge Herrero Moreno in RNA Formulation**

Introduction

Jorge Herrero Moreno is an accomplished inventor based in Mainz, Germany, recognized for his innovative work in the field of RNA delivery systems. With a focus on enhancing the efficacy of RNA therapeutics, he has made significant strides in the formulation of compositions intended for parenteral administration. His expertise is underscored by his patent, which has potential applications in various medical fields.

Latest Patents

Jorge Herrero Moreno holds a patent for a formulation for the administration of RNA. This invention pertains to compositions that feature polyplex formulations designed for the targeted delivery of RNA to specific organs or cells, particularly following intramuscular injections. The formulations include polyplex particles created from single-stranded RNA and polyalkyleneimine, which facilitate effective RNA administration. This innovation is vital for advancing RNA-based therapies, offering new possibilities in medical treatment.

Career Highlights

Throughout his career, Jorge has been associated with notable companies, including BioNTech SE and TRON (Translational Oncology at the University Medical Center of Johannes Gutenberg University Mainz). His tenure at these leading research institutions has allowed him to contribute significantly to the development of novel therapeutic strategies and innovative healthcare solutions.

Collaborations

During his professional journey, Jorge Herrero Moreno has collaborated with distinguished colleagues, such as Ugur Sahin and Heinrich Haas. These partnerships have enriched his research efforts and fostered an environment of innovation at the intersections of biotechnology and medicine.

Conclusion

Jorge Herrero Moreno's contributions to RNA formulation and delivery systems exemplify the transformative potential of innovation in healthcare. His patent represents a significant achievement in the field, reflecting his dedication to advancing therapeutic approaches. The impact of his work resonates within the realms of biotechnology and medicine, paving the way for future advancements in RNA-based treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…